サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：高血圧治療薬の中国市場
市場調査レポート
商品コード
86341

高血圧治療薬の中国市場

Hypertension Drugs Markets in China
出版日: | 発行: Asia Market Information & Development Co. | ページ情報: 英文 215 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.46円
高血圧治療薬の中国市場
出版日: 2023年11月27日
発行: Asia Market Information & Development Co.
ページ情報: 英文 215 Pages
納期: 即納可能 即納可能とは
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、中国の高血圧治療薬市場について調査分析し、需要と業界動向の予測や、事業環境、市場参入についての情報を提供しています。

目次

第1章 イントロダクション

  • 調査範囲と調査手法
  • エグゼクティブサマリー

第2章 事業環境

  • 経済の見通し
  • 主要経済指標
  • 工業生産
  • 人口と労働力
  • 外国投資
  • 外国貿易
  • 財務と税金の規制
  • 銀行システムと規制
  • 外国為替
  • 税金と関税

第3章 高血圧治療薬業界の評価

  • 高血圧治療薬業界構造
  • 市場規模
  • 市場の成長促進要因
  • 高血圧治療薬の販売量
  • 主な生産施設の場所
  • 主要生産者の販売量と市場シェア
  • 人件費
  • 潜在的な参入企業
  • 主な販売業者
  • 主な外国投資
  • 技術開発

第4章 高血圧治療薬の生産と需要

  • 市場の概要：医薬品分類別
  • カルシウムチャネル遮断薬
  • フェロジピン
  • ニフェジピン
  • アムロジピン
  • ニソルジピン
  • ニモジピン
  • ニトレンジピン
  • アンジオテンシンII受容体拮抗薬
  • ロサルタン
  • バルサルタン
  • イルベサルタン
  • テルミサルタン
  • カンデサルタン
  • アンジオテンシン変換酵素阻害薬
  • ベナゼプリル
  • エナラプリル
  • カプトプリル
  • リシノプリル
  • ラミプリル
  • その他の高血圧治療薬
  • 輸入と輸出
  • 市場の概要：生産者別
  • 価格動向

第5章 高血圧治療薬市場の見通し

  • 高血圧治療薬市場の見通しの概要
  • 政府の規制
  • 医療保険業界の概要
  • 消費者支出の動向
  • 北東
  • 北
  • 南東
  • 中部
  • 南西
  • 北西
  • 人口動態の動向
  • 医療業界の動向
  • 病院と病床

第6章 マーケティング戦略

  • 中国市場参入の概要
  • 中国の流通システム
  • 高血圧治療薬の流通チャネル
  • 輸送と貨物のインフラ
  • コミュニケーション
  • 中国市場参入
  • ライセンシング
  • フランチャイズ
  • eコマース
  • 商社と現地の代理店
  • 駐在員事務所と中国の子会社
  • 完全外資企業

第7章 高血圧治療薬生産者ディレクトリ

  • 高血圧治療薬生産者のプロファイルと業界における主な消費
図表

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. HYPERTENSION DRUGS INDUSTRY ASSESSMENTS

  • Calcium Channel Blocker Sales Volume and Market Share by Drugs Classification
  • Angiotensin II Receptor Antagonists Drug Sales Volume and Market Share by Drugs Classification
  • Angiotensin-Converting Enzyme Inhibitor Sales Volume and Market Share by Drugs Classification
  • Other Hypertension Drugs Sales Volume and Market Share by Drugs Classification
  • Hypertension Drugs Sales Volume
  • Major Producer Facility Location
  • Major Hypertension Drugs Producer Sales Volume
  • Major Foreign Investment in China

IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND

  • Hypertension Drugs Sales Volume by Drugs Classification
  • Calcium Channel Blocker Sales Volume and Market Share by Drugs Classification
  • Angiotensin II Receptor Antagonists Drug Sales Volume and Market Share by Drugs Classification
  • Angiotensin-Converting Enzyme Inhibitor Sales Volume and Market Share by Drugs Classification
  • Other Hypertension Drugs Sales Volume and Market Share by Drugs Classification
  • Hypertension Drugs Import by Drugs Classification
  • Hypertension Drugs Export by Drugs Classification
  • Hypertension Drugs Major Producer, Sales Volume, and Market Share

V. HYPERTENSION DRUGS MARKET OUTLOOK

  • Consumer Spending Trends
  • The Structure of Per Capita Expenditure in the Northeast of China
  • The Structure of Per Capita Expenditure in the North of China
  • The Structure of Per Capita Expenditure in the Southeast of China
  • The Structure of Per Capita Expenditure in the Central of China
  • The Structure of Per Capita Expenditure in the Southwest of China
  • The Structure of Per Capita Expenditure in the Northwest of China
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds

LIST OF CHARTS

I. INTRODUCTION

  • Hypertension Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. HYPERTENSION DRUGS INDUSTRY ASSESSMENTS

  • Total Hypertension Drugs Sales Volume
  • Hypertension Drugs Sales Volume by Drugs Classification
  • Calcium Channel Blocker Market Share by Drugs Classification
  • Angiotensin-Converting Enzyme Inhibitor Market Share by Drugs Classification
  • Angiotensin II Receptor Antagonists Drug Market Share by Drugs Classification
  • Other Hypertension Drugs Market Share by Drugs Classification
  • Hypertension Drugs Sales Volume

IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND

  • Hypertension Drugs Sales Volume
  • Hypertension Drugs Import
  • Hypertension Drugs Export
  • Hypertension Drugs Sales Volume by Drugs Classification
  • Calcium Channel Blocker Sales Volume and Market Share
  • Calcium Channel Blocker Market Share by Drugs Classification
  • Angiotensin II Receptor Antagonists Drug Sales Volume and Market Share
  • Angiotensin II Receptor Antagonists Drug Market Share by Drugs Classification
  • Angiotensin-Converting Enzyme Inhibitor Sales Volume and Market Share
  • Angiotensin-Converting Enzyme Inhibitor Market Share by Drugs Classification
  • Other Hypertension Drugs Sales Volume and Market Share
  • Other Hypertension Drugs Market Share by Drugs Classification
  • Hypertension Drugs Import by Drugs Classification
  • Calcium Channel Blocker Import and Market Share
  • Angiotensin II Receptor Antagonists Drug Import and Market Share
  • Angiotensin-Converting Enzyme Inhibitor Import and Market Share
  • Other Hypertension Drugs Import and Market Share
  • Hypertension Drugs Export by Drugs Classification
  • Calcium Channel Blocker Export and Market Share
  • Angiotensin-Converting Enzyme Inhibitor Export and Market Share
  • Angiotensin II Receptor Antagonists Drug Export and Market Share
  • Other Hypertension Drugs Export and Market Share

VI. MARKETING STRATEGIES

  • China's Distribution Channel
目次
Product Code: 808

China's demand for Hypertension Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. HYPERTENSION DRUGS INDUSTRY ASSESSMENTS

  • Hypertension Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Hypertension Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producers' Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND

  • Market Overview by Drugs Classification
  • Calcium Channel Blocker
  • Felodipine
  • Nifedipine
  • Amlodipine
  • Nisoldipine
  • Nimodipine
  • Nitrendipine
  • Angiotensin II Receptor Antagonists Drug
  • Losartan
  • Valsartan
  • Irbesartan
  • Telmisartan
  • Candesartan
  • Angiotensin-Converting Enzyme Inhibitor
  • Benazepril
  • Enalapril
  • Captopril
  • Lisinopril
  • Ramipril
  • Other Hypertension Drugs
  • Import and Export
  • Market Overview by Producers
  • Pricing Trend

V. HYPERTENSION DRUGS MARKET OUTLOOK

  • Hypertension Drugs Markets Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Northeast
  • North
  • Southeast
  • Central
  • Southwest
  • Northwest
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. HYPERTENSION DRUGS PRODUCER DIRECTORY

  • Profiles of Hypertension Drugs Producers and Major Consumption in Industry